chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Elevated fasting blood glucose levels; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6205) in the left arm on 12Mar2021 at 12:15 (at the age of 64-year-old) as a single dose and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8735) in the left arm on 02Apr2021 at 12:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included elevated blood glucose levels, but under control with diet and exercise, A1C was 5.6. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within four weeks prior to the vaccination. On 12Mar2021 at 17:30 hours, the patient experienced elevated fasting blood glucose levels. The patient had noticed elevated fasting blood glucose levels after the first shot. During the 3 weeks between shots, his fasting blood glucose (BG) readings were 100 or greater all but once. Many readings were well above 100 (as high as 115). He had been carefully regulating his carbs for the last year and he kept track of everything he eats, so these were unusual. After the 2nd shot, his blood glucose reading was unusually high after his first meal, but his fasting readings had been back to nearly normal (100 - 101). The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event elevated fasting blood glucose levels was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Initial case received from a pediatrician on 04 June 2011. An 11-year-old female patient, with no reported history, received the following vaccines on 17 May 2011: ADACEL (lot number C3518AA, MENACTRA (lot number U3779AA), hepatitis B (manufacturer and lot not reported), and VARIVAX (lot not reported). Within 2 weeks of vaccination, the patient developed a swan finger deformity, with muscle spasms and tightness. She was evaluated by orthopedic specialists, and per the reporter no cause had been established. No additional information was reported.
I am breastfeeding my daughter and the day after the vaccine I had bright red blood discharge. This was well after my delivery. I had not had my period yet and still do not have it. This was an isolated event and only happened once, the day after the vaccine.  Has not occurred again.
Emesis x 1 day then fevers up to 104F.  Seizure (unwitnessed) on 11/14/21 Hypotension, cough congestion, respiratory distress, hemoptysis, elevated troponins and proBNP  Required BiPAP and ICU admission. ECHO 11/16/21 showed some diastolic dysfunction.
confusion, light headed,  walls closing in, can't handle being in crowds; confusion, light headed,  walls closing in, can't handle being in crowds; confusion, light headed,  walls closing in, can't handle being in crowds; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confusion, light headed,  walls closing in, can't handle being in crowds), DIZZINESS (confusion, light headed,  walls closing in, can't handle being in crowds) and PANIC ATTACK (confusion, light headed,  walls closing in, can't handle being in crowds) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     Blood pressure, heartburn, back pain.     On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) unknown. On 20-May-2021, the patient experienced CONFUSIONAL STATE (confusion, light headed,  walls closing in, can't handle being in crowds), DIZZINESS (confusion, light headed,  walls closing in, can't handle being in crowds) and PANIC ATTACK (confusion, light headed,  walls closing in, can't handle being in crowds). At the time of the report, CONFUSIONAL STATE (confusion, light headed,  walls closing in, can't handle being in crowds), DIZZINESS (confusion, light headed,  walls closing in, can't handle being in crowds) and PANIC ATTACK (confusion, light headed,  walls closing in, can't handle being in crowds) had not resolved.            Blood pressure, heartburn, back pain -test are done No treatment medication was provided No concomitant medication was provided
Went numb on left side - beginning with tongue and lips - up into eye and ear - then into arm and leg and hand and foot. Stayed like that for about 3 hours. Days after - same effects occurred when consuming Triscuits, wheat thins, Deli Ham and Toco Bell
Patient reports that as her injection was given, the vaccine solution was running down her arm. Following her COVID shot, she was administered the flu shot. After the flu shot was administered, the pharmacist expressed that he thought the patient did not receive the full initial COVID shot dose and asked if he could administer an additional 5 mg. The patient consented to do so. That night, the patient reports experiencing body aches. The following morning she woke up with extreme body aches and a low-grade fever which reached 103 F during the day. The fever did not break until 3:00 AM the following morning.
Headache, fever, malaise, nausea, disruption in menstrual cycle, pain in injection arm
This spontaneous report as received from a pharmacist refers to a female patient of approximately 63 years old. Current conditions and medical history was not reported. On 03-OCT-2014, the patient was vaccinated with ZOSTAVAX vial, subcutaneous (dose and frequency were not reported). Concomitant medication were not reported. On 07-OCT-2014, patient came into the pharmacy and presented with a non-vesicular rash at injection site on an unknown date in October 2014. The pharmacist described the rash as red and approximately 1 and half inches in diameter around the injection site. The pharmacist advised the patient to put ice on the injection site. The outcome of the events was reported as not recovered. Causality assessment was not reported. Patient sought medical attention by visiting the pharmacy on 07-OCT-2014. Product quality complaint was not reported. Additional information has been requested.
Employee stated that after receiving COVID #1 on 4/5 she started having left arm numbness and weakness. Symptoms started the same day, progressed from knuckles up to shoulder. I assessed hand grips, left hand grip was slightly weaker and shaky. As of 5/5, employee's left arm has improved, but her left hand still has numbness, tingling, and a slightly weaker grip - symptoms have not worsened.
Pt reported dizziness and blurred vision after shot. Called Nurse to recheck and follow up. See Nurse comments.
Arm was red and sore the following day, with a small lump at injection site. One week later, arm is still red and hot to the touch. No pain associated.
vaccines in his L arm 14JUN2021 and 1hour later experienced 7/10 pain in the joints of his L arm along w/ nerve pain and fevers of 101.5 with nausea. pt reports going ER and states he was discharged and advised to take benadryl.  Pt currently is no longer feeling nauseous and states his temperatures are around 99.7. pt states his pain is now a dull 3/10 pain and radiates to his hand. NO weakness. No rash, erythema or swelling. Continues with Benadryl at night.
indication=Treatment of COVID-19; indication=Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 65-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 01Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported and no other medications the patient received within 2 weeks of vaccination. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 11May2022, outcome "not recovered" and all described as "indication=Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11May2022) positive; (19May2022) Negative; (27May2022) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started on 12May2022 and stopped on 17May2022.   Clinical course was reported as, Symptom onset and positive test 11May2022, Paxlovid initiated 12May2022 and completed 17May2022. Negative test 19May2022 Symptom re-emergence 26May2022, positive test 27May2022.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and the Drug ineffective and Covid 19 cannot be completely excluded.
TENDER AREA AROUND VACCINATION SITE, WARM FEEL LIKE. UPON EXAMINATION, THERE IS A 2 INCHES RED AREA AROUND VACCINATION SITE, TENDER AND HARD.
Inflammation of lymph node in left arm pit.  Pain at inflammation site.   Treatment has been ibuprofen 600-800 mg once daily for pain and swelling as well as downward massage of arm pit.  Ice to site too.    The swelling started on Saturday night while also experiencing chills, muscle pain, joint pain, and nausea.  The swelling is worse in the morning.   It continues to swell at this documentation time.
recent diagnosis of COVID pneumonia on 1/30/22 in the setting of increasing fatigue, sore throat, cough, wheezing, shortness of breath, abdominal pain, and generalized weakness. She was hospitalized from 1/30 - 2/06/22 in the setting of her pneumonia and was discharged home with new oxygen requirements. Patient states that she normally does not use oxygen at home, but has been using 1L of supplemental oxygen since her COVID diagnosis. She endorses an ongoing cough, wheezing, and shortness of breath but has otherwise been back to her normal state of health.
Stinging, burning, welt, Rash at injection site happened within 1st 12-24 hours rash then went down the arm and included all other symptoms listed here :nausea, vomiting, muscle aches and severe muscle leg cramps, chills, lightheaded, fatigue, headaches, diarrhea dizzy, heart racing, heartburn. I still have heart racing episodes and it scares me my heart has been affected.
Fever; Stomach upset; Chills; A little bit of body aches; Headache; We both had sore arms; This is a spontaneous report from a contactable consumer. A 75-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration at the age of 75 years, on 01Feb2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included myocardial infarction from an unknown date and unknown if ongoing. The caller stated, "Heart attack about 12 or 13 years ago." The patient also had a stent placement from an unknown date and unknown if ongoing. It was stated, "He has three stents in his arteries". Concomitant medication included acetylsalicylic acid (BABY ASPIRIN), metoprolol (METOPROLOL) and rosuvastatin (ROSUVASTATIN). The patient received first dose of COVID vaccine BNT162B2 at the age of 75 years on Jan2021 at a single dose for COVID-19 immunization. The patient's wife stated, "My husband and I, both got our second shot of Pfizer COVID Vaccine yesterday. Just late this afternoon (02Feb2021), he had a fever of 101.5 which has come down now because he took some Tylenol, had a stomach upset and chills and a little bit of body aches and headaches. Is this the normal reaction that has been with the Pfizer Vaccine?" It was stated, "I think he is feeling a lot better. He took two Tylenol and his fever has gone down to 98.7." It was further stated, "I have a sore arm and it is much better today but it is still just little tender that is the only thing I had. His arm was pretty sore yesterday as well." The wife stated, "Yesterday, just shortly after we both got the shot. We both had sore arms by the time we drove home, yesterday afternoon, 1Feb2021. My arm is slightly stiff still, just the muscle is slightly sore and I think, my husband is feeling a lot better today too, just slightly sore." The patient underwent lab tests and procedures which included body temperature: 101.5 on 02Feb2021 and body temperature: 98.7 on Feb2021. Therapeutic measures were taken as a result of fever (pyrexia). The outcome of the events was unknown.   Information on lot number/batch number has been requested.
Information has been received on 13-DEC-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 10-APR-2014, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 05-NOV-2015, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is not recovered. The causality of the events is related. Additional information has been requested.
PASSED OUT PROBABLY NOT RELACTED TO SHOT.   PATIENT RECENTLY WAS IN HOSPITAL AND RECENTLY DISCHAGED BECAUSE OF COVID 19
Fever; body aches; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Fever) and MYALGIA (body aches) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 prophylaxis.     The patient's past medical history included Sick sinus syndrome. Concurrent medical conditions included Obesity (Obesity Confirmed. Started in high school, extra 15 pounds has been whole life.) and Pacemaker syndrome (Pacemaker Passed out and pulse got down to 32 and had sick sinus syndrome, ultimate diagnosis.) since 12-Jun-2017. Concomitant products included VITAMIN B [VITAMIN B NOS] and VITAMIN D NOS for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and MYALGIA (body aches). At the time of the report, PYREXIA (Fever) and MYALGIA (body aches) outcome was unknown.            No treatment medication reported by reporter.   This case was linked to MOD-2022-618147, MOD-2022-618090 (Patient Link).
In between my first and second shots I started having pain in my right side back and right side front. Dull kinda pain, soreness...not super sharp or anything. It was severe enough that I couldn't sleep at night.  I still kept my second vaccine appointment which was in a couple days and booked an appt. with my doctor. It was about a week until I could get in to the office. In that time I got a small herpetic rash about the size of two fifty cent pieces on my right side. I went to the office and the doctor identified it as Shingles...which is not something I've had before. He put me on an oral steroid for 6 days, anti-viral medicine(Valacyclovir), and something for nerve pain (Gabapentin). All of which helped and I appear to have recovered so far.
Fever 101.5 at highest  Severe body aches Moderate to strong ache at inject site, radiating to shoulder Severe fatigue
Seriousness criteria other medically significant (OMIC). Initial report received on 8/17/06 from in investigator participating in the above mentioned trial. A 17 year old male subject developed Bells palsy eight days post immunization, after receiving the study vaccine Adacel, lot number C2151AC on 11/7/05. The subject also received the same day a dose of Menactra vaccine, lot number U1769AA. The routes and sites of administration were not reported. the subject had a history of allergy to Ibuprofen and concurrent otitis media that was being treated with amoxicillin and A/B otic drops on 11/7/05. The strep A probe throat culture was negative that day on suspected A beta hemolytic streptococcus by DNA probe assay. Eight day post immunization, the subject developed paralysis of the right side of his face. The mother stated that the pt could not move his face on one side. The subject denied any numbness or paralysis of any other body parts. He denied slurred speech. The subject stated his eye on that side was having muscle spasms. On examination, the subject had moderate right facial palsy with maintenance of eye closed with some effort, some lip elevation and forehead wrinkling. The subject was diagnosed with Bells palsy and started on Acyclovir and prednisone. The subject also complained of dizziness and possible hearing loss in the right ear with ongoing ear pain. The following day the subject underwent right myringotomy and tube placement. The subject was seen in the physicians office 35 days later, and it was noted that the facial palsy had cleared within two weeks of having the myringotomy and tube placement. According to the investigator, the event of Bells palsy was possibly related to the study vaccine and to the Menactra vaccine. Documents held by sender: Doctor visit notes.
Caller: parent called at 3:09 PM (04/04/2018). Call Taken By: RN. Concerns/Comments: Spoke with Mother, states patients arm is red and tender at the injection site after her first dose of Bexsero yesterday/ mom also states that her arm "feels tingly" and her muscle is sore. I explained that a sore injection site can occur for 1-2 days in 50% of patients and joint pain is common in 20% of patients after this vaccine. Mom denies any discharge/streaking at the site/ patient also denies any fever. Offered Mother appt for today but she would like to monitor patient, advised mother to use a cold ice pack for pain for 20 mins each hour, and TYLENOL or ADVIL can also be given as needed. Advised Mother to call back if redness becomes larger/ pain, swelling, or redness gets worse after 3 days or a fever starts after 2 days.
Moderate joint aches across entire body. Moderate fatigue. Alternating fever (unknown temperature) and chills.
pt arm & neck became swollen p/vax;pt was advised to take DPH;the swelling went away p/using DPH;
whole body was itchy; Tongue tingling and numb/lips tingling and numb; lump in the back of her throat; Tongue tingling and numb/lips tingling and numb; A spontaneous report (UNITED STATES) was received from a 57-years-old consumer who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events whole body was itchy, tongue tingling and numb/lips tingling and numb and lump on the back of her throat.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 05-FEB-2021, prior to the onset of the events the consumer received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly in right arm for prophylaxis of COVID-19 infection.  On 05-FEB-2021, the consumer experienced the events whole body was itchy, tongue tingling and numb/lips tingling and numb and lump on the back of her throat. The reporter mentioned that she had to be transported to the ER from the vaccination center.  Treatment information included benadryl.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events was considered unknown.; Reporter's Comments: This case concerns a 57 Y/O  hospitalized with serious unexpected events of pruritus, paraesthesia oral, hypoaesthesia oral and sensation of foreign body. Event onset the same day as first dose mRNA-1273. Treated with diphenhydramine.  Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initial reaction: pain at the injection site, nausea  Delayed reaction: red circle, swelling, itching, pain to touch, fever at the injection site. Now it has a double red ring.
Abdominal pain transcend, lower quads. U/A, CBC, CMP - normal.
Patient needed second dose of Moderna vaccine and we ended up giving Pfizer dose instead of moderna  . Patient is still doing great with  no side effect
Intermittent rapid heart rate; Severe migraine; Headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 05Mar2021 at 07:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies and penicillin allergy. Concomitant medications included dexlansoprazole (DEXILANT). The patient previously took clarithromycin, erythromycin (reported as arythromicin), acetaminophen (TYLENOL) and all for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 05Mar2021 at 19:00, in the evening after receiving the first dose the patient experienced intermittent rapid heart rate which lasted several days, headache for 2 days and severe migraine lasted for a day. The events resulted in doctor or other healthcare professional office or clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
10/11-redness swelling itch @infection site of 7 days 10/12-seen at health center redness. 70x50 with indurated area at site of infection. Temp normal. Ibuprofen, ice, Lombadine 10/13-seen at health center less redness but induration remains and itching 10/16-itch, redness but 25x15mm induration remains 11/6 20x10mm nodule palpated slight tender with deep palpation
Immunization given on 3/27/09 3 hours after going to bed woke up screaming for 5-10 min. did settle some fussy till TYLENOL kicked in temp 103 degrees then given TYLENOL @ 11 PM; 4AM and 8AM temp decreased to 100 degrees. Seen 3/28/09 2-3cm red induration without heat on Rt thigh (IVP and PREVNAR) slight swelling 3/30/09 still somewhat fussy no temp - sites look better.